MTEM.Q logo

Molecular Templates Stock Price

Symbol: OTCPK:MTEM.QMarket Cap: US$658.0Category: Pharmaceuticals & Biotech

MTEM.Q Share Price Performance

US$0.0001
-1.41 (-99.99%)
US$0.0001
-1.41 (-99.99%)
Price US$0.0001

MTEM.Q Community Narratives

There are no narratives available yet.

MTEM.Q Community Fair Values

    Recent MTEM.Q News & Updates

    No updates

    Molecular Templates, Inc. Key Details

    US$25.5m

    Revenue

    US$29.2m

    Cost of Revenue

    -US$3.8m

    Gross Profit

    US$11.9m

    Other Expenses

    -US$15.6m

    Earnings

    Last Reported Earnings
    Jun 30, 2024
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -2.37
    Gross Margin
    -14.75%
    Net Profit Margin
    -61.35%
    Debt/Equity Ratio
    0%

    Molecular Templates, Inc. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About MTEM.Q

    Founded
    2001
    Employees
    62
    CEO
    Craig Jalbert
    WebsiteView website
    www.mtem.com

    Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB). It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas. On April 20, 2025, Molecular Templates, Inc. along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

    U.S. Market Performance

    • 7 Days: -2.7%
    • 3 Months: 10.7%
    • 1 Year: 17.5%
    • Year to Date: 5.9%
    In the last week, the market has fallen 2.7%, dragged down most by the Financials. In the last year, the market is actually up 18%. Earnings are forecast to grow by 15% annually. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading